More on SPPI
Data
Financials
News
Click line-items for a historical chart and %
| Product sales, net | 30.27M |
| License and contract revenue | |
| Total revenues | 33.39M |
| Cost of product sales (excludes amortization of purchased intangible assets) | |
| Selling, general and administrative | 19.47M |
| Research and development | 13.29M |
| Amortization of purchased intangibles | |
| Total operating costs and expenses | 49.39M |
| Income (loss) from operations | -16M |
| Change in fair value of common stock warrant liability | |
| Other income, net | 372K |
| Income (loss) before provision for income taxes | -17.92M |
| Provision for income taxes | 500K |
| Net income (loss) | |
| Basic | |
| Diluted | |
| Basic | |
| Diluted | |
Entities mentioned with SPPI
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Jefferies & Co | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- IPO | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
